Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Organovo Holdings Inc (NASDAQ:ONVO)

2.94
Delayed Data
As of Dec 02
 +0.05 / +1.73%
Today’s Change
1.60
Today|||52-Week Range
4.99
+18.07%
Year-to-Date

Today’s Trading

Previous close2.89
Today’s open2.89
Day’s range2.87 - 3.06
Volume998,955
Average volume (3 months)1,093,065
Market cap$305.4M
Dividend yield--
Data as of 12/02/2016

Growth & Valuation

Earnings growth (last year)-13.16%
Earnings growth (this year)+9.30%
Earnings growth (next 5 years)--
Revenue growth (last year)+159.72%
P/E ratioNM
Price/Sales131.78
Price/Book4.37

Competitors

 Today’s
change
Today’s
% change
CGENCompugen Ltd+0.10+1.71%
ADAPAdaptimmune Therapeu...-0.11-2.64%
GERNGeron Corp+0.05+2.55%
NVAXNovavax Inc+0.06+5.08%
Data as of 12/02/2016

Financials

Next reporting dateFebruary 13, 2017
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$1.5M
Annual profit (last year)-$38.6M
Net profit margin-2,601.15%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Keith Murphy
Chief Financial Officer
Craig S. Kussman
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs